CN Patent

CN112839935A — 可用作shp2抑制剂的新型杂环衍生物

Assigned to Jacobio Pharmaceuticals Co Ltd · Expires 2021-05-25 · 5y expired

What this patent protects

提供了式I所示的化合物，它们的合成以及它们用于治疗SHP2介导的疾病的用途。更具体地，提供了包含所述化合物的药物组合物。

USPTO Abstract

提供了式I所示的化合物，它们的合成以及它们用于治疗SHP2介导的疾病的用途。更具体地，提供了包含所述化合物的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112839935A
Jurisdiction
CN
Classification
—
Expires
2021-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Jacobio Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.